Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

New hirudin option now available in U.K.

April 27, 1998

Markers of thrombin and their relation to clinical outcome after myocardial infarction

April 23, 1998

Effects of aspirin + ticlopidine combination antiplatelet therapy following stent implantation

April 20, 1998

Genentech claims TF-FVIIa hybrids for coagulation disorders

April 16, 1998

Benefits of abciximab therapy in coronary stent deployment and coronary angioplasty

April 16, 1998

Ibex Technologies initiates phase III testing of Neutralase

April 15, 1998

Heparinase I pharmacokinetics evaluated in healthy volunteers

April 8, 1998

Factor Xa inhibitor selected for clinical trials at Berlex Biosciences

April 8, 1998

New factor Xa inhibitors designed at DuPont Merck

April 8, 1998

RPR-130737, a potent nonpeptidyl inhibitor of factor Xa

April 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...